Icosavax
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Icosavax's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 93% to $582,000. Profit margin reached -15199%. Total operating expenses were $95,058,000.
Profit Margin
| 2019 | 0 | -5.19M | |
|---|---|---|---|
| 2020 | 1.61M | -19.18M | -1187.19% |
| 2021 | 7.80M | -67.99M | -871.56% |
| 2022 | 582K | -88.45M | -15198.97% |
ICVX Income Statement (2019 – 2022)
| 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|
Revenue | ||||
Revenue | 582K | 7.80M | 1.61M | 0 |
Cost of revenue | 1.84M | 82K | 17.66M | 4.15M |
Gross profit | -1.26M | 7.72M | -16.05M | -4.15M |
Operating exp. | ||||
Research and development | 65.41M | 38.77M | 17.66M | 4.15M |
Selling and marketing | 0 | 0 | 0 | 0 |
Total operating expenses | 95.05M | 65.86M | 18.71M | 5.39M |
Operating income | -95.05M | -65.86M | -18.71M | -5.39M |
Other income (expenses), net | 3.3M | -1.11M | -144K | 101K |
Income before tax | -91.75M | -66.97M | -18.85M | -5.29M |
Income tax expense | -3.29M | 1.02M | 331K | -101K |
Net income | -88.45M | -67.99M | -19.18M | -5.19M |
Earnings per share | ||||
Basic EPS | -2.23 | -3.78 | -6.67 | -0.51 |
Diluted EPS | -2.23 | -3.78 | -6.67 | -0.51 |
| Data source | Data source |